HSP90B1 and hepatocellular carcinoma: HLA-A2.1/Kb transgenic mice immunized with Pgp96-pulsed marrow-derived dendritic cells (BMDCs) exhibited a significant increase in HepG2-specific T cells, an HLA-A2-positive HCC cell line (Fig. 1b) and an enhanced cytotoxic effect compared to that in mice immunized with recombinant gp96-pulsed or unpulsed BMDCs (Fig. 1c).